Colgate Palmolive Co SEC Filings

Colgate-Palmolive reported Q3 2025 results with net sales of $5,131 and diluted EPS of $0.91. Net income attributable to the company was $735. For the first nine months, net sales were $15,152 and diluted EPS reached $2.67, up from $2.61 a year ago.

The company completed the acquisition of Care TopCo Pty Ltd (Prime100) for AU $471 (approximately $301) on April 30, 2025, expanding Hill’s into fresh pet food in Australia. It also announced a three‑year Strategic Growth and Productivity Program with estimated cumulative pre‑tax charges between $200 and $300, with substantially all charges expected by December 31, 2028.

In the quarter, parties entered into a settlement agreement to resolve an ERISA lawsuit for $332, which received preliminary court approval in October 2025; a final approval hearing is scheduled for January 2026. Nine‑month cash from operations was $2,745; financing included dividends of $1,300 and treasury share purchases of $804. Shares outstanding were 806,064,942 as of September 30, 2025.

Colgate-Palmolive (CL) filed an 8-K stating it furnished a press release announcing earnings for the quarter ended September 30, 2025, and outlined expected costs for a new three-year Strategic Growth and Productivity Program.

The program is estimated to result in cumulative pre-tax charges of $200 to $300 million. The Company expects 65% to 75% to be employee-related costs (severance and other termination benefits) and 25% to 35% to be asset-related and other charges (accelerated depreciation, asset write-offs, contract termination and other exit costs). It estimates 75% to 85% of these charges will require cash expenditures, with substantially all charges incurred by December 31, 2028. The Company indicates the charges will relate to initiatives across regions and businesses: North America (15% to 20%), Latin America (15% to 20%), Europe (10% to 15%), Asia Pacific (10% to 15%), Africa/Eurasia (5% to 10%), Hill’s Pet Nutrition (10% to 15%), and Corporate (10% to 15%).

Brian Newman, a director of Colgate-Palmolive Co. (CL), reported a non-derivative acquisition of 228 shares of common stock on 10/01/2025 at a price of $82.13 per share. Following the transaction he directly beneficially owns 5,065 shares and indirectly holds 36 shares through a family trust. The filing identifies the purchase code A(1), and the explanation states this represents a portion of the annual cash retainer deferred into a stock unit account under the company’s Deferred Compensation Plan for Non-Employee Directors. The Form 4 was signed by an attorney-in-fact on 10/03/2025.

Lorrie M. Norrington, a director of Colgate-Palmolive Company (CL), reported a transaction dated 10/01/2025 in which she acquired 319 shares of Colgate common stock at a price of $82.13 per share. After this transaction she beneficially owned 39,061 shares in a direct ownership form. The filing states the purchase reflects a portion of an annual cash retainer deferred into a stock unit account under the company’s Deferred Compensation Plan for Non-Employee Directors. The Form 4 was signed by an attorney-in-fact on 10/03/2025.

John P. Bilbrey, a director of Colgate-Palmolive Company (CL), reported an acquisition on 10/01/2025 of 289 shares of the issuer's common stock at a price of $82.13 per share. Following the transaction, Mr. Bilbrey directly beneficially owns 36,658 shares and indirectly owns 4,719 shares through a trust. The filing states the reason for the acquisition: a portion of his annual cash retainer was deferred into a stock unit account under the company’s Deferred Compensation Plan for Non-Employee Directors, resulting in the issuance of common stock.

The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 10/03/2025. No derivative transactions, dispositions, or other changes are disclosed in this Form 4.

Jennifer Daniels, CLO and Secretary of Colgate-Palmolive Company (CL), reported insider dispositions on 09/12/2025 and 09/13/2025. The filings show withholding of 521 shares on 09/12/2025 at $83.28 per share and withholding of 900 shares on 09/13/2025 at $83.28 per share, reducing her direct beneficial ownership to 76,559 shares. In addition, she is shown as beneficially owning 1,813 shares indirectly held by the issuer's 401(k) plan trustee. The filer explains these dispositions were withholdings to satisfy tax liabilities arising from the vesting of restricted stock units under the companys incentive plan.

Insider share withholding for tax on vested RSUs — The Form 4 shows John Hazlin, listed as Chief Growth Officer and officer of Colgate-Palmolive Co (CL), reported share dispositions on 09/12/2025 and 09/13/2025. The filings record withholding of 377 and 449 shares respectively at an implied price of $83.28 per share to satisfy tax liabilities from the vesting of restricted stock units.

After these withholdings Hazlin beneficially owns 17,629 shares directly and 5,382 shares indirectly through the issuer's 401(k) plan trustee. The Form 4 was signed by an attorney-in-fact and includes the standard explanation that the transactions were share withholdings for tax payment.

Malcolm Gregory, listed as Executive Vice President and Controller of Colgate-Palmolive Company (CL), reported routine share withholding to cover tax liabilities from vesting restricted stock units. The form shows two small dispositions: 89 shares disposed on 09/12/2025 and 152 shares disposed on 09/13/2025, each at a price of $83.28. After the 09/12 transaction he beneficially owned 12,057 shares directly and after 09/13 he beneficially owned 11,905 shares directly. He also holds 8,445 shares indirectly through the issuer's 401(k) plan trustee. The filing explains these dispositions were the withholding of shares to pay tax on vested restricted stock units. The form is signed on behalf of the reporting person by an attorney-in-fact.

Sally Massey, Chief Human Resources Officer of Colgate-Palmolive Company, reported the withholding and disposal of shares to cover taxes on vested restricted stock units. The filing shows two non-derivative transactions: 447 shares disposed on 09/12/2025 at $83.28 and 669 shares disposed on 09/13/2025 at $83.28, a total of 1,116 shares sold to satisfy tax withholding. After these transactions she beneficially owned 14,946 shares directly, and additionally held 8,004 shares indirectly through the issuer's 401(k) plan trustee. The form was signed by an attorney-in-fact on 09/16/2025. The filer explained the disposals were withholdings for tax liability incident to RSU vesting.